Isicom (Levodopa, Carbidopa Monohydrate)

Levodopa is a precursor of dopamine that can cross the blood‑brain barrier. Once inside the central nervous system, it is converted to dopamine, compensating for the neurotransmitter loss that characterises Parkinsonian disorders. Carbidopa blocks peripheral conversion of levodopa, increasing the amount that reaches the brain and reducing gastrointestinal side effects.

The appropriate dose of Isicom is individualized by the prescribing clinician based on the patient’s disease severity, response to therapy, age, and comorbid conditions. Dosage adjustments are made during treatment to balance symptom control with tolerability, and patients should follow the prescriber’s specific instructions.

Safety data for levodopa/carbidopa during pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To request Isicom, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Isicom combines levodopa with carbidopa, offering rapid symptomatic relief by directly replenishing dopamine. Other classes, such as dopamine agonists or MAO‑B inhibitors, act indirectly and may have different side‑effect profiles. Levodopa/carbidopa remains the most effective option for advanced motor symptoms, while adjunctive agents are often added to manage fluctuations or reduce levodopa dose.

Store Isicom at below 25 °C (77 °F) in a dry place. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children. Do not store in a refrigerator or freezer unless specifically instructed by the supplier.

Isicom is taken orally, usually with a small amount of food to improve tolerability. Tablets should be swallowed whole with water and not crushed or chewed unless the prescriber advises otherwise. The exact timing and frequency are determined by the treating physician based on individual therapeutic response.

Serious adverse events include dyskinesia (involuntary movements), severe hypotension, psychiatric disturbances such as hallucinations or psychosis, and rare occurrences of neuroleptic malignant syndrome. Patients should be educated to report sudden changes in mood, severe dizziness, or unexplained muscle movements promptly to their healthcare provider.

Isicom is contraindicated in patients with known hypersensitivity to levodopa, carbidopa, or any excipients in the formulation. It should also be avoided in individuals taking non‑selective MAO inhibitors or those with narrow‑angle glaucoma, malignant melanoma, or a history of severe cardiovascular disease unless specifically directed by a specialist.